Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-26

Clinical Trial Update: Intermittent Fasting and Metabolic Dysfunction Associated Fatty Liver Disease [NA]

View source ↗

Summary

The ClinicalTrials.gov study from Istanbul Bilgi University evaluating intermittent fasting for metabolic dysfunction-associated fatty liver disease has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Istanbul Bilgi University | Conditions: Intermittent Fasting, Metabolic Dysfunction-Associated Fatty Liver Disease | NA | Status: COMPLETED | Results posted: 2025-06-26